GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CollPlant Biotechnologies Ltd (NAS:CLGN) » Definitions » Shiller PE Ratio

CollPlant Biotechnologies (CollPlant Biotechnologies) Shiller PE Ratio : (As of Jun. 06, 2024)


View and export this data going back to 2021. Start your Free Trial

What is CollPlant Biotechnologies Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


CollPlant Biotechnologies Shiller PE Ratio Historical Data

The historical data trend for CollPlant Biotechnologies's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CollPlant Biotechnologies Shiller PE Ratio Chart

CollPlant Biotechnologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CollPlant Biotechnologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CollPlant Biotechnologies's Shiller PE Ratio

For the Biotechnology subindustry, CollPlant Biotechnologies's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CollPlant Biotechnologies's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CollPlant Biotechnologies's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where CollPlant Biotechnologies's Shiller PE Ratio falls into.



CollPlant Biotechnologies Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

CollPlant Biotechnologies's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, CollPlant Biotechnologies's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.37/131.7762*131.7762
=-0.370

Current CPI (Mar. 2024) = 131.7762.

CollPlant Biotechnologies Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.003 100.560 -0.004
201409 -0.003 100.428 -0.004
201412 -0.480 99.070 -0.638
201503 -0.003 99.621 -0.004
201506 -0.005 100.684 -0.007
201509 -0.004 100.392 -0.005
201512 -0.996 99.792 -1.315
201603 -0.024 100.470 -0.031
201606 -0.018 101.688 -0.023
201609 -0.016 101.861 -0.021
201612 -0.017 101.863 -0.022
201703 -0.011 102.862 -0.014
201706 0.011 103.349 0.014
201709 0.008 104.136 0.010
201712 -0.012 104.011 -0.015
201803 -0.010 105.290 -0.013
201806 -0.007 106.317 -0.009
201809 -0.290 106.507 -0.359
201812 0.005 105.998 0.006
201903 -0.480 107.251 -0.590
201906 -0.270 108.070 -0.329
201909 -0.680 108.329 -0.827
201912 -0.800 108.420 -0.972
202003 -0.240 108.902 -0.290
202006 -0.280 108.767 -0.339
202009 0.070 109.815 0.084
202012 -0.420 109.897 -0.504
202103 0.880 111.754 1.038
202106 -0.300 114.631 -0.345
202109 -0.290 115.734 -0.330
202112 -0.390 117.630 -0.437
202203 -0.360 121.301 -0.391
202206 -0.390 125.017 -0.411
202209 -0.400 125.227 -0.421
202212 -0.390 125.222 -0.410
202303 -0.330 127.348 -0.341
202306 0.490 128.729 0.502
202309 -0.380 129.860 -0.386
202312 -0.420 129.419 -0.428
202403 -0.370 131.776 -0.370

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


CollPlant Biotechnologies  (NAS:CLGN) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


CollPlant Biotechnologies Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of CollPlant Biotechnologies's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CollPlant Biotechnologies (CollPlant Biotechnologies) Business Description

Traded in Other Exchanges
Address
4 Oppenheimer Street, P.O. Box 4132, Weizmann Science Park, Rehovot, ISR, 7670104
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The company's revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing.